论文信息 - First-in-human phase I/II, open-label study of the anti-OX40 agonist INCAGN01949 in patients with advanced solid tumors - 字舞流文

First-in-human phase I/II, open-label study of the anti-OX40 agonist INCAGN01949 in patients with advanced solid tumors

D. Cho | J. Janik | R. Kristeleit | E. Davis | T. Condamine | S. Blagden | Xuejun Chen | J. Mehnert | Rowan E Miller | Jason Clark | D. Cardin | M. Vieito | K. Spencer | A. Orcurto | Dominik Berthold | J. Martín-Liberal | J. Pulini | Prashanth Hari Dass | E. J. Davis